Ad
AMGN Short Information Amgen Inc.
home / stock / amgn / amgn short
Short Information | Amgen Inc. (NASDAQ:AMGN)
| Twenty Trading Day Totals | |
|---|---|
| Total Shorted Volume | 13,990,903 |
| Total Actual Volume | 92,614,531 |
| Short Trends | |
|---|---|
| Cover Days | 20 |
| Short Days | 0 |
| No Change Days | 0 |
| Averages | |
|---|---|
| Average Short Volume | 699,545 |
| Average Short Percentage | 14.20% |
Is there a AMGN Short Squeeze or Breakout about to happen?
See the AMGN Short Analysis for free Sign up or Login
Powered by Squeeze Report
AMGN Twenty Trading Day's Volume to Short Volume Chart
AMGN Twenty Trading Day Price Chart
AMGN Short Data Results Days
| Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
|---|---|---|---|---|---|---|---|
| 12-12-2024 | $273.81 | $274.06 | $275.875 | $272.15 | 3,474,022 | 437,342 | 12.59% |
| 12-11-2024 | $276 | $273.41 | $276.28 | $270.58 | 4,493,511 | 458,828 | 10.21% |
| 12-10-2024 | $277.86 | $275.75 | $277.9 | $272.36 | 2,791,398 | 404,579 | 14.49% |
| 12-09-2024 | $273.16 | $277.63 | $280 | $272.28 | 3,222,458 | 462,652 | 14.36% |
| 12-06-2024 | $275.01 | $272.58 | $275.355 | $271.48 | 3,970,337 | 377,200 | 9.5% |
| 12-05-2024 | $277 | $274.33 | $279.04 | $273.15 | 3,186,985 | 463,427 | 14.54% |
| 12-04-2024 | $275.81 | $278.26 | $279.41 | $273.855 | 4,174,137 | 556,838 | 13.34% |
| 12-03-2024 | $277 | $278.32 | $281.3799 | $276.5 | 5,468,847 | 686,254 | 12.55% |
| 12-02-2024 | $282.08 | $278.1 | $282.391 | $276.89 | 4,677,815 | 705,247 | 15.08% |
| 11-29-2024 | $279.455 | $282.87 | $283.64 | $277.64 | 2,232,846 | 307,546 | 13.77% |
| 11-27-2024 | $279 | $280.07 | $282.69 | $278 | 6,622,764 | 1,249,589 | 18.87% |
| 11-26-2024 | $264.22 | $280.01 | $280.34 | $257.8 | 17,010,332 | 3,523,675 | 20.71% |
| 11-25-2024 | $293.55 | $294 | $297.3235 | $293.5001 | 4,695,856 | 424,677 | 9.04% |
| 11-22-2024 | $290.84 | $294.53 | $295.48 | $288.78 | 3,053,317 | 679,337 | 22.25% |
| 11-21-2024 | $288.18 | $289.9 | $291.11 | $284.1435 | 3,553,436 | 525,999 | 14.8% |
| 11-20-2024 | $281.1 | $287.87 | $288.48 | $278.56 | 4,759,332 | 568,668 | 11.95% |
| 11-19-2024 | $277.67 | $279.95 | $281.5997 | $275.56 | 3,210,454 | 435,850 | 13.58% |
| 11-18-2024 | $279.38 | $278.76 | $281.36 | $276.56 | 3,175,879 | 399,518 | 12.58% |
| 11-15-2024 | $291.5 | $283.61 | $291.5 | $279.62 | 5,325,131 | 807,776 | 15.17% |
| 11-14-2024 | $297.91 | $295.93 | $298.48 | $292.325 | 3,515,674 | 515,901 | 14.67% |
News, Short Squeeze, Breakout and More Instantly...
Ad
-
2024-12-12 14:23:18 ET It's been a banner year for the stock market. However, not every stock has been a winner as some sectors performed better than others. Tech and utilities soared, while others like real estate and healthcare underperformed. So what are the five worst performers on ...
-
AMGEN ANNOUNCES 2025 FIRST QUARTER DIVIDEND PR Newswire THOUSAND OAKS, Calif. , Dec. 10, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.38 per share dividend for the first quarter of 2025. The dividend will ...
-
2024-12-10 09:38:59 ET Biotech companies are making monumental strides in cancer treatment, leveraging cutting-edge technologies to redefine the field. Given the robust prospect, investors looking for fundamentally sound biotech stocks might consider adding Regeneron Pharmaceuticals (REGN...